Omeros Corporation (3O8)
FSX
Closed
Aug 27, 2026
Day's Range
15.4552 wk Range
3.35Overview - 3O8 - Omeros Corporation
Key Statistics
Valuation
Enterprise Value
1.14B
P/E (Trailing)
‪11.57‬
P/E (Forward)
‪-12.73‬
PEG Ratio
‪-0.04‬
Price / Sales (TTM)
‪31.18‬
Price / Book
‪-18.73‬
EV / EBITDA
‪-18.65‬
Profitability
Gross Margin
‪94.06%‬
Profit Margin
‪324.88%‬
Operating Margin
‪0.25%‬
Return on Assets
‪-18.67%‬
Return on Equity
‪2.76%‬
Ownership
Shares Outstanding
71.99M
Float
69.28M
Held by Insiders
‪4.08%‬
Held by Institutions
‪50.58%‬
Price stats
Beta
‪2.53‬
50-Day Avg
‪9.97‬
200-Day Avg
‪9.90‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - 3O8 - Omeros Corporation
Peers - 3O8 - Omeros Corporation
Peer Comparison
Compared with companies in Biotechnology listed on FSX.
- 3O8FSXOmeros Corporation505.17MMarket Cap+63.50%52-week change6.98P/E (Trailing)‪871.02%‬Profit Margin
- ANLFSXAnalog Devices, Inc.155.08BMarket Cap+30.19%52-week change43.54P/E (Trailing)‪29.78%‬Profit Margin
- 1AEFSXargenx SE54.76BMarket Cap+32.87%52-week change39.76P/E (Trailing)‪32.26%‬Profit Margin
- 1AEAFSXargenx SE American Depositary Receipt53.48BMarket Cap+32.20%52-week change39.13P/E (Trailing)‪32.26%‬Profit Margin
- 0QFFSXModerna, Inc.50.94BMarket Cap+83.58%52-week change25.27P/E (Trailing)‪-141.42%‬Profit Margin
- 42ZFSXRevolution Medicines Inc.40.44BMarket Cap+82.94%52-week change-31.71P/E (Trailing)‪0.00%‬Profit Margin
- 49BAFSXBeOne Medicines, Ltd. American Depositary Receipt35.97BMarket Cap+19.62%52-week change65.00P/E (Trailing)‪10.69%‬Profit Margin
Profile Summary - 3O8 - Omeros Corporation
About
Omeros Corporation is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing small-molecule and protein therapeutics. It targets large-market opportunities as well as orphan indications, particularly in areas such as inflammation, coagulopathies, disorders of the central…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
